熱門資訊> 正文
GOEV、NBSE和FLGC在上市前的输家中
2024-03-26 20:15
- Losers: NeuBase Therapeutics (NBSE) -58%.
- AppTech Payments Corp (APCX) -41% announces proposed underwritten public offering.
- Ampio Pharmaceuticals (AMPE) -38% announces voluntary delisting and SEC deregistration.
- Tivic Health Systems (TIVC) -16% after Q3 earnings release.
- Cardlytics (CDLX) -12% on proposed $150M convertible notes offering.
- Dada Nexus Ltd (DADA) -11% after Q4 earnings release.
- eFFECTOR Therapeutics (EFTR) -8% after Q4 earnings release.
- Bioline Rx Ltd (BLRX) -8% after FY earnings release.
- MAIA Biotechnology (MAIA) -7% looks to raise $1.33M through a private placement.
- Global Mofy Metaverse Ltd (GMM) -7%.
- MicroAlgo (MLGO) -7%.
- Canoo (GOEV) -6%.
- Flora Growth Corp (FLGC) -5%.
- Bluebird bio (BLUE) -5% reports Q4 results.
More on Pre-market losers & stocks.
- Canoo: Positive News Isn't Enough
- Canoo: Avoid After Reverse Stock Split
- Canoo: There Is A Glimpse Of Hope But Hold
- Canoo completes acquisition of manufacturing assets from Arrival
- Canoo's manufacturing facility gets foreign trade zone status; shares rise ~59%
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
